Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
140.50    3.25 (2.36%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £110.25m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Trading Update

7 Jul 2011 07:00

RNS Number : 9205J
Xaar PLC
07 July 2011
 



 

FOR IMMEDIATE RELEASE

7 July 2011

 

 

Xaar plc

 

 

INTERIM TRADING UPDATE

 

 

Xaar plc ("Xaar" or the "Group"), the inkjet printing technology group headquartered in Cambridge, presents an update on trading performance for the period ended 30 June 2011.

 

Trading

 

Revenue in the first half of 2011 was ahead of the board's expectations, being in excess of £31m (H1 2010: £23.8m, H2 2010; £30.9m).

 

Sales of Platform 3 ("P3") products (which are still capacity constrained), were stronger than expected due to both productivity gains and the impact of the early stages of the capacity ramp programme. The critical stages in the capacity ramp are still to be completed as planned during the second half of 2011 and first half of 2012. Platform 1 ("P1") revenues were below the board's expectations.

 

Manufacturing output and the P3 capacity expansion programme have been unaffected by the disaster in Japan earlier in the year.

 

Cash

 

The Group continues to maintain a strong balance sheet with net cash at 30 June 2011 of £20.6 million (31 December 2010 - £22.0 million, 30 June 2010 - £8.2 million).

 

Dividend

 

It is the Board's intention to pay an interim dividend, details of which will be provided at the time of the announcement of the interim results.

 

Announcement of interim results

 

The full results for the six months ended 30 June 2011 will be announced, in accordance with Xaar's normal timetable, on 18 August 2011.

 

Director retirement

 

After 6 years with Xaar, Phil Eaves, Sales and Marketing Director, has announced his intention to retire in June 2012. A process has commenced to ensure his successor is in place during Q2 2012.

 

Ends

 

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7626

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRFMFTMBJMBRB
Date   Source Headline
21st Sep 20239:57 amRNSHolding(s) in Company
19th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20232:11 pmRNSHolding(s) in Company
11th Sep 202312:14 pmRNSHolding(s) in Company
11th Sep 202312:07 pmRNSHolding(s) in Company
11th Sep 202312:03 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
11th Sep 202312:02 pmRNSHolding(s) in Company
7th Sep 20239:00 amRNSNotice of 2023 Half Year Results
1st Sep 20239:30 amRNSTotal Voting Rights
25th Aug 202312:13 pmRNSHolding(s) in Company
23rd Aug 202310:24 amRNSHolding(s) in Company
18th Aug 202310:30 amRNSChange of Auditor
17th Aug 202312:55 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSTrading Update
1st Aug 20232:00 pmRNSTotal Voting Rights
28th Jul 20234:30 pmRNSHolding(s) in Company
5th Jul 20239:00 amRNSXaar plc - Commercial partnership with Quantica
4th Jul 20233:00 pmRNSBlock listing Interim Review
3rd Jul 20232:53 pmRNSTotal Voting Rights
1st Jun 202310:37 amRNSTotal Voting Rights
31st May 202311:30 amRNSResult of AGM
31st May 20239:00 amRNSBoard Changes
11th May 20235:41 pmRNSHolding(s) in Company
10th May 20233:10 pmRNSDirector/PDMR Shareholding
2nd May 202312:39 pmRNSTotal Voting Rights
24th Apr 20231:05 pmRNSAnnual Financial Report
3rd Apr 20234:51 pmRNSTotal Voting Rights
28th Mar 20237:00 amRNSFinal Results
20th Mar 20232:00 pmRNSNotification of the 2022 Full Year Results Date
1st Mar 20233:19 pmRNSTotal Voting Rights
20th Feb 202312:35 pmRNSHolding(s) in Company
1st Feb 202312:30 pmRNSTotal Voting Rights
30th Jan 202312:30 pmRNSHolding(s) in Company
12th Jan 20237:00 amRNSTrading Update
5th Dec 202210:21 amRNSDirector/PDMR Shareholding
1st Dec 202210:19 amRNSTotal Voting Rights
21st Nov 20224:41 pmRNSSecond Price Monitoring Extn
21st Nov 20224:35 pmRNSPrice Monitoring Extension
3rd Nov 20221:38 pmRNSGrant of Sharesave Options
1st Nov 202210:41 amRNSTotal Voting Rights
13th Oct 20222:20 pmRNSHolding(s) in Company
3rd Oct 20224:07 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNS2022 INTERIM RESULTS
1st Sep 20225:32 pmRNSTotal Voting Rights
30th Aug 202210:26 amRNSNotice of 2022 Half Year Results
1st Aug 20224:33 pmRNSTotal Voting Rights
1st Aug 202211:25 amRNSHolding(s) in Company
14th Jul 20227:00 amRNSTrading Update
1st Jul 20221:14 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.